We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
(+21%)
Cap. Flow
+$404M
Cap. Flow
% of AUM
6.55%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$197M |
| 2 |
AGN
Allergan plc
AGN
|
+$135M |
| 3 |
Bausch Health
BHC
|
+$129M |
| 4 |
CVS Health
CVS
|
+$107M |
| 5 |
McKesson
MCK
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$286M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$225M |
| 3 |
Gilead Sciences
GILD
|
+$86.1M |
| 4 |
Perrigo
PRGO
|
+$79.4M |
| 5 |
Cardinal Health
CAH
|
+$74.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.16% |
| 2 | Consumer Discretionary | 5.06% |
| 3 | Energy | 4.01% |
| 4 | Utilities | 3.23% |
| 5 | Financials | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Veeva Systems
VEEV
$33.1B
| $247K | ﹤0.01% |
+9,206
| New | +$298K |
|
|
CAB
727
DELISTED
Cabela's Inc
CAB
| $247K | ﹤0.01% |
+3,763
| New | +$253K |
|
728
First Horizon
FHN
$12.2B
| $246K | ﹤0.01% |
19,875
-25,793
| -56% | -$307K |
|
|
AAN.A
729
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $246K | ﹤0.01% |
+8,126
| New | +$246K |
|
730
Best Buy
BBY
$18.2B
| $245K | ﹤0.01% |
9,272
-7,743
| -46% | -$212K |
|
731
Intel
INTC
$455B
| $245K | ﹤0.01% |
9,491
-1,082
| -10% | -$27K |
|
732
Eversource Energy
ES
$26.9B
| $244K | ﹤0.01% |
5,351
-251,946
| -98% | -$11M |
|
|
CBI
733
DELISTED
Chicago Bridge & Iron Nv
CBI
| $244K | ﹤0.01% |
+2,794
| New | +$227K |
|
734
AES
AES
$10.5B
| $243K | ﹤0.01% |
16,999
-98,877
| -85% | -$1.4M |
|
|
ABCO
735
DELISTED
Advisory Board Co
ABCO
| $243K | ﹤0.01% |
+3,772
| New | +$239K |
|
736
Jabil
JBL
$33B
| $242K | ﹤0.01% |
13,395
-26,800
| -67% | -$483K |
|
|
XLNX
737
DELISTED
Xilinx Inc
XLNX
| $242K | ﹤0.01% |
+4,451
| New | +$221K |
|
|
TRW
738
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
| $242K | ﹤0.01% |
+2,960
| New | +$230K |
|
|
SCG
739
DELISTED
Scana
SCG
| $241K | ﹤0.01% |
4,687
-18,104
| -79% | -$871K |
|
740
LPL Financial
LPLA
$28.3B
| $240K | ﹤0.01% |
+4,559
| New | +$241K |
|
741
Host Hotels & Resorts
HST
$17.2B
| $238K | ﹤0.01% |
+11,748
| New | +$228K |
|
742
AutoZone
AZO
$49.2B
| $237K | ﹤0.01% |
441
-48
| -10% | -$24.9K |
|
743
State Street Materials Select Sector SPDR ETF
XLB
$8.5B
| $237K | ﹤0.01% |
10,000
-30,000
| -75% | -$690K |
|
|
SFLY
744
DELISTED
Shutterfly, Inc.
SFLY
| $237K | ﹤0.01% |
+5,545
| New | +$264K |
|
745
Tesla
TSLA
$1.23T
| $236K | ﹤0.01% |
+16,935
| New | +$227K |
|
746
Kirby Corp
KEX
$7.01B
| $235K | ﹤0.01% |
2,317
+250
| +12% | +$25.2K |
|
747
Live Nation Entertainment
LYV
$40.6B
| $235K | ﹤0.01% |
+10,791
| New | +$234K |
|
748
SPX Corp
SPXC
$11B
| $235K | ﹤0.01% |
9,471
-6,016
| -39% | -$154K |
|
749
Procter & Gamble
PG
$336B
| $234K | ﹤0.01% |
2,900
-15,285
| -84% | -$1.2M |
|
750
Tractor Supply
TSCO
$16.1B
| $234K | ﹤0.01% |
+16,525
| New | +$234K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.
- Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
- Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
- Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
- Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
- Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
- Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
- Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.
Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.